Citius Oncology (CTOR) Accumulated Expenses (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Accumulated Expenses of $4.1 million for Q1 2026, down 53.42% year-over-year from $8.7 million in Q1 2025, and little changed quarter-over-quarter from $4.1 million in Q4 2025.
Citius Oncology (CTOR) Accumulated Expenses (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Accumulated Expenses for 4 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 53.42% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 53.42% YoY), while the FY2025 annual figure was $4.1 million, changed N/A from the prior year.
- Accumulated Expenses held at $4.1 million in Q1 2026 per CTOR's latest filing, from $4.1 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $8.7 million in Q1 2025 and bottomed at $60000.0 in Q4 2023.
- Historically, Accumulated Expenses has averaged $3.6 million across 4 years, with a median of $4.1 million in 2025.
- Annual changes were most pronounced in 2024 — Accumulated Expenses jumped 10281.02% — and 2026, when it tumbled 53.42%.
- Citius Oncology's Accumulated Expenses stood at $60000.0 in 2023, then surged by 10281.02% to $6.2 million in 2024, then tumbled by 34.78% to $4.1 million in 2025, then changed by 0.0% to $4.1 million in 2026.
- Business Quant data shows CTOR's Accumulated Expenses at $4.1 million in Q1 2026, $4.1 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Citius Oncology | 81.99 Mn | 81.99 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 8.46 Mn |
| Mar 31, 2025 | 8.72 Mn |
| Dec 31, 2024 | 6.23 Mn |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Dec 31, 2023 | 60,000.00 |
| Sep 30, 2023 | 259,071.00 |